Assertio Holdings, Inc. (ASRT)Healthcare | Drug Manufacturers - Specialty & Generic | Lake Forest, United States | NasdaqCM
23.48 USD
+0.01
(0.043%)
⇧
(June 12, 2026, 4 p.m.
EDT)
After hours: 23.46 -0.02 (-0.020%) ⇩ (June 12, 2026, 7:16 p.m. EDT) |
Hot Take ↕ | June 12, 2026, 7:32 p.m. EDT
The most critical signal here is the active tender offer priced at $23.50 per share, which effectively caps the stock's upside while providing a hard floor. The market has already priced in this acquisition premium, as the current price sits virtually at the offer level. While the buyout provides a safety net, the underlying business is struggling significantly, with revenue contracting by over 60% and operating margins deeply negative. The lack of dividends and the deteriorating operational metrics suggest that the long-term value lies entirely in the sale, not in the company's organic growth. Investors should view this as a short-term arbitrage play on the deal completion rather than a long-term equity investment in the business itself. |
| Model | MAE |
|---|---|
| MSTL_79_105 ✓ | 0.485694 |
| MSTL_79 | 0.488500 |
| MSTL | 0.508725 |
| AutoETS | 0.510041 |
| AutoARIMA | 0.510042 |
| MSTL_105 | 0.517485 |
| AutoTheta | 0.527447 |
Forecast horizon: 60 days | Selected: MSTL_79_105
| Forecast Reliability | |
|---|---|
| Score | 29% |
| H-stat | 2.83 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.005 |
| Excess Kurtosis | 0.50 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 53.302 |
| Revenue per Share | 15.92 |
| Market Cap | 151,731,984 |
| Forward P/E | 9.10 |
| Beta | 0.53 |
| Profit Margins | -34.94% |
| Website | https://www.assertiotx.com |
As of June 12, 2026, 7:32 p.m. EDT: Implied volatility remains exceptionally low across expirations, suggesting low speculative fervor. Open interest is heavily concentrated in deep in-the-money calls for the near term, indicating hedging or assignment risk rather than pure bullish speculation. September puts show notable open interest at lower strikes, reflecting a hedge against a potential deal failure or price collapse below the tender offer threshold.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.408205 |
| Address1 | 100 South Saunders Road |
| Address2 | Suite 300 |
| All Time High | 2,024.4 |
| All Time Low | 7.65 |
| Ask | 26.78 |
| Ask Size | 1 |
| Audit Risk | 3 |
| Average Daily Volume10 Day | 341,280 |
| Average Daily Volume3 Month | 338,660 |
| Average Volume | 338,660 |
| Average Volume10Days | 341,280 |
| Beta | 0.531 |
| Bid | 20.19 |
| Bid Size | 1 |
| Board Risk | 3 |
| Book Value | 11.735 |
| City | Lake Forest |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 23.48 |
| Current Ratio | 1.822 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,780,012,800 |
| Day High | 23.5 |
| Day Low | 23.48 |
| Debt To Equity | 53.302 |
| Display Name | Assertio |
| Earnings Call Timestamp End | 1,773,693,000 |
| Earnings Call Timestamp Start | 1,773,693,000 |
| Earnings Timestamp | 1,773,691,200 |
| Earnings Timestamp End | 1,786,392,000 |
| Earnings Timestamp Start | 1,786,392,000 |
| Ebitda | 3,827,000 |
| Ebitda Margins | 0.03746 |
| Enterprise To Ebitda | 31.481 |
| Enterprise To Revenue | 1.179 |
| Enterprise Value | 120,475,984 |
| Eps Current Year | -1.24 |
| Eps Forward | 2.58 |
| Eps Trailing Twelve Months | -5.55 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 510 744 8001 |
| Fifty Day Average | 21.0778 |
| Fifty Day Average Change | 2.4021988 |
| Fifty Day Average Change Percent | 0.113968186 |
| Fifty Two Week Change Percent | 140.8205 |
| Fifty Two Week High | 23.5 |
| Fifty Two Week High Change | -0.020000458 |
| Fifty Two Week High Change Percent | -0.0008510833 |
| Fifty Two Week Low | 8.61 |
| Fifty Two Week Low Change | 14.87 |
| Fifty Two Week Low Change Percent | 1.7270616 |
| Fifty Two Week Range | 8.61 - 23.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 881,159,400,000 |
| Float Shares | 6,264,825 |
| Forward Eps | 2.58 |
| Forward P E | 9.100776 |
| Free Cashflow | 7,750,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 53 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,780,531,200 |
| Gross Margins | 0.70332 |
| Gross Profits | 71,850,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01968 |
| Held Percent Institutions | 0.29304 |
| Implied Shares Outstanding | 6,462,180 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,766,707,200 |
| Last Split Factor | 1:15 |
| Long Business Summary | Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois. |
| Long Name | Assertio Holdings, Inc. |
| Market | us_market |
| Market Cap | 151,731,984 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_363049 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -35,690,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 151,667,364 |
| Number Of Analyst Opinions | 3 |
| Open | 23.48 |
| Operating Cashflow | -7,081,000 |
| Operating Margins | -1.85946 |
| Overall Risk | 1 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.89 |
| Phone | 224 419 7106 |
| Post Market Change | -0.020000458 |
| Post Market Change Percent | -0.08518083 |
| Post Market Price | 23.46 |
| Post Market Time | 1,781,306,193 |
| Previous Close | 23.47 |
| Price Eps Current Year | -18.935484 |
| Price Hint | 2 |
| Price To Book | 2.000852 |
| Price To Sales Trailing12 Months | 1.4852678 |
| Profit Margins | -0.34936002 |
| Quick Ratio | 1.453 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0100002 |
| Regular Market Change Percent | 0.0426086 |
| Regular Market Day High | 23.5 |
| Regular Market Day Low | 23.48 |
| Regular Market Day Range | 23.48 - 23.5 |
| Regular Market Open | 23.48 |
| Regular Market Previous Close | 23.47 |
| Regular Market Price | 23.48 |
| Regular Market Time | 1,781,294,401 |
| Regular Market Volume | 485,056 |
| Return On Assets | -0.057129998 |
| Return On Equity | -0.38759 |
| Revenue Growth | -0.625 |
| Revenue Per Share | 15.92 |
| Sand P52 Week Change | 0.23177934 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 6,462,180 |
| Shares Percent Shares Out | 0.051799998 |
| Shares Short | 334,922 |
| Shares Short Previous Month Date | 1,777,507,200 |
| Shares Short Prior Month | 289,282 |
| Short Name | Assertio Holdings, Inc. |
| Short Percent Of Float | 0.0525 |
| Short Ratio | 0.71 |
| Source Interval | 15 |
| State | IL |
| Symbol | ASRT |
| Target High Price | 28.0 |
| Target Low Price | 21.8 |
| Target Mean Price | 24.43333 |
| Target Median Price | 23.5 |
| Total Cash | 71,569,000 |
| Total Cash Per Share | 11.075 |
| Total Debt | 40,313,000 |
| Total Revenue | 102,158,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -5.55 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.39195 |
| Two Hundred Day Average Change | 9.08805 |
| Two Hundred Day Average Change Percent | 0.6314676 |
| Type Disp | Equity |
| Volume | 485,056 |
| Website | https://www.assertiotx.com |
| Zip | 60,045 |